BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Receivables - Net (2010 - 2025)

Updated

BioLineRx (BLRX) reported Receivables - Net of $46,000 for the quarter ended Dec 31, 2025, down 98.1% from $2.48 million a year earlier.

Analysis

BioLineRx (BLRX) Receivables - Net (2010 - 2025) Analysis & Trends

Dating back to the quarter ended Dec 31, 2010, BioLineRx's Receivables - Net record includes 9 quarters.

  • By year, Receivables - Net came in at $2.48 million in the year ended Dec 31, 2024 (+591.6%) and $358,000 in the year ended Dec 31, 2023.
  • The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Receivables - Net in data going back to the quarter ended Dec 31, 2010.
  • Year over year, Receivables - Net gained in 1 of the last four quarters, with growth averaging 87.0%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 46,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 1.47 Mn
Dec 31, 2024 2.48 Mn
Sep 30, 2024 3.61 Mn
Jun 30, 2024 3.18 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 358,000.00
Dec 31, 2010 5.29 Mn
API Access

BioLineRx Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=BLRX&period=max&api_key=YOUR_API_KEY